Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.045 USD | -3.24% | -5.50% | -44.50% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.91M | Capitalization | 72.21M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.86 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.42 x |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-0.9
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Bionano Genomics, Inc.
1 day | -5.26% | ||
1 week | +4.85% | ||
Current month | +22.30% | ||
1 month | +44.00% | ||
3 months | -10.74% | ||
6 months | -26.03% | ||
Current year | -42.86% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +11.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.045 | -3.24% | 154 814 |
24-05-20 | 1.08 | -5.26% | 1,225,894 |
24-05-17 | 1.14 | +2.70% | 869,873 |
24-05-16 | 1.11 | -3.48% | 1,468,694 |
24-05-15 | 1.15 | +3.60% | 2,412,188 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.86% | 72.21M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.23% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- BNGO Stock